|
USP15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.538600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.606500E-02 |
| Normal-vs-Stage2 |
3.219000E-01 |
| Normal-vs-Stage3 |
7.290000E-01 |
| Normal-vs-Stage4 |
6.127800E-01 |
| Stage1-vs-Stage2 |
1.372110E-02 |
| Stage1-vs-Stage3 |
9.240300E-03 |
| Stage1-vs-Stage4 |
3.578200E-01 |
| Stage2-vs-Stage3 |
4.117400E-01 |
| Stage2-vs-Stage4 |
2.141000E-01 |
| Stage3-vs-Stage4 |
4.101600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.598600E-01 |
| Normal-vs-AfricanAmerican |
7.041000E-01 |
| Normal-vs-Asian |
3.078100E-02 |
| Caucasian-vs-AfricanAmerican |
8.638400E-01 |
| Caucasian-vs-Asian |
3.923600E-02 |
| AfricanAmerican-vs-Asian |
1.234950E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.665570E-01 |
| Normal-vs-Female |
3.756400E-01 |
| Male-vs-Female |
4.237000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.798400E-03 |
| Normal-vs-Age(41-60Yrs) |
8.028000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.366400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.199800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.384100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.374400E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.698010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.796400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.797800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.839600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.956500E-04 |
| Classical-VS-Follicular |
6.345900E-02 |
| Classical-VS-Other |
7.292800E-01 |
| Classical-VS-Normal |
2.881700E-02 |
| Tall-VS-Follicular |
3.877800E-01 |
| Tall-VS-Other |
2.135200E-01 |
| Tall-VS-Normal |
1.942030E-01 |
| Follicular-VS-Other |
7.297600E-01 |
| Follicular-VS-Normal |
8.134400E-01 |
| Other-VS-Normal |
6.357200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.123600E-01 |
| Normal-vs-N1 |
9.900400E-02 |
| N0-vs-N1 |
1.628830E-01 |
|
|
